Stockreport

TFF Pharmaceuticals enters pact for dry powder mRNA-based Covid treatment [Seeking Alpha]

TFF Pharmaceuticals, Inc.  (TFFP) 
PDF Biomedical Advanced Research and Development Authority (BARDA) to develop a dry powder inhaled mRNA-based treatment for influenza and Covid. Under the partnership , fu [Read more]